AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17697449
Drug: Etoricoxib (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib (90 mg daily)
Trial: 12009282
Drug: SPf66/QS-21 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPf66/QS-21 vaccine
Trial: 12009282
Drug: SPf66/alum vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPf66/alum vaccine
Trial: 7301160
Drug: Preoperative skin
RxNorm normalized name: POVIDONE-IODINE 75 mg in 1 mL TOPICAL SOLUTION [Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative skin disinfection with povidone-iodine 10% (Betadine) and application of 10% povidone-iodine solution before skin closure.
Trial: 23999674
Drug: High AA
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High AA group: 3 g/kg/d of parenteral amino acids, increasing by 1 g/kg daily until a maximum of 4 g/kg/d
Trial: 19016815
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics (ciprofloxacin and metronidazole)
Trial: 12795852
Drug: Paclitaxel liposome
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel liposome at 135 mg/m² each session, combined with ADM or DDP for two cycles (3 weeks per cycle)
Trial: 11017151
Drug: Altered peptide
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Altered peptide ligand of myelin basic protein (5 mg)
Trial: 2873863
Drug: Intravenous somatostatin
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous somatostatin (100 micrograms/h)
Trial: 31962348
Drug: Evidence-based rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based rehabilitation treatments
Trial: 31962348
Drug: Alternative research
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative research designs (e.g. case-control studies, cohort studies, observational studies)
Trial: 20124885
Drug: Metoprolol 5
RxNorm normalized name: metoprolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 5 mg intravenously three times at 2‐min intervals
Trial: 11058482
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal patch (21 mg/day) with typical antipsychotic medications
Trial: 11058482
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal patch (21 mg/day) with either atypical or typical antipsychotic medications
Trial: 11058482
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal patch (21 mg/day) with atypical antipsychotic medications
Trial: 1279502
Drug: Cocaine solution
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine solution
Trial: 1279502
Drug: Xylometazoline/lidocaine solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylometazoline/lidocaine solution
Trial: 16021649
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine once daily at bedtime
Trial: 16021649
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin (once- or twice-daily)
Trial: 16021649
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (for those on >1 basal insulin injection prior to study)
Trial: 16021649
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin (for those on >1 basal insulin injection prior to study)
Trial: 12540987
Drug: Nebivolol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (2.5 mg and 5 mg, n = 6)
Trial: 8694155
Drug: mivacurium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mivacurium 0.2 mg.kg‐1
Trial: 8694155
Drug: anaesthetic drugs
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anaesthetic drugs alone
Trial: 1459169
Drug: MaxEPA (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MaxEPA (3 g n-3 fatty acids)
Trial: 3902241
Drug: Benzydamine hydrochloride
RxNorm normalized name: benzydamine hydrochloride
DrugBank: Benzydamine (DB09084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine hydrochloride solution
Trial: 20424555
Drug: L-arginine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (12 g daily)
Trial: 19078834
Drug: Prehospital abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prehospital abciximab treatment
Trial: 15950849
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of 15 mL of 0.5% bupivacaine
Trial: 7669649
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg SDZ IMM 125 daily
Trial: 2257964
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg cimetidine taken once nightly
Trial: 31937137
Drug: Revascularization +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revascularization + best medical therapy + structured exercise therapy
Trial: 22013800
Drug: Fuzheng Huayu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuzheng Huayu Capsule
Trial: 19222595
Drug: Carisbamate 100
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 100 mg/day
Trial: 19222595
Drug: Carisbamate 300
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 300 mg/day
Trial: 19222595
Drug: Carisbamate 600
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 600 mg/day
Trial: 11104316
Drug: CC (community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC (community comparison group)
Trial: 8082361
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 20 mg by mouth, three times a day for 7 days
Trial: 919994
Drug: Mechanical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical preparation with antibiotics (lincomycline, neomycine, polymyxine, kanamycine, bacitracine, nystatine)
Trial: 919994
Drug: Mechanical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical preparation alone
Trial: 919994
Drug: Postoperative use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative use of antibiotics for local or general infection
Trial: 24975892
Drug: Bixalomer 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bixalomer 1.5 g/day
Trial: 24975892
Drug: Bixalomer 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bixalomer 3.0 g/day
Trial: 24975892
Drug: Bixalomer 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bixalomer 4.5 g/day
Trial: 22559260
Drug: Bare-metal stent
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bare-metal stent implantation followed by post-dilation with a drug-eluting balloon (n=10)
Trial: 22271159
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg dapagliflozin
Trial: 15287853
Drug: lamivudine‐interferon (IFN)‐alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamivudine‐interferon (IFN)‐alpha combination therapy
Trial: 1583328
Drug: IL-1 production
RxNorm normalized name: IL-1 TRAP
DrugBank: Rilonacept (DB06372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-1 production post-therapy
Trial: 27203302
Drug: G1‐PLUS™/G2‐PLUS™ sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G1‐PLUS™/G2‐PLUS™ sequential medium (Vitrolife)
Trial: 22886839
Drug: Warm humidified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm humidified CO₂ (37°C, 100% relative humidity, 10 L/min)
Trial: 17358101
Drug: Pantoprazole 20mg
RxNorm normalized name: pantoprazole 20 MG
DrugBank: Pantoprazole (DB00213)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pantoprazole 20mg on-demand treatment
Trial: 17358101
Drug: Esomeprazole 20mg
RxNorm normalized name: ESOMEPRAZOLE 20MG (BASE) CAP,EC
DrugBank: Esomeprazole (DB00736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20mg on-demand treatment
Trial: 17184890
Drug: Topiramate (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (200 mg)
Trial: 2137435
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 0.200 mg
Trial: 6988949
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative dose of tinidazole 2 g and doxycycline 200 mg (n = 70)
Trial: 25616223
Drug: Coarse CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coarse CAP (2.5‐10 μm; mean, 213 μg/m3)
Trial: 25616223
Drug: Ultrafine CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrafine CAP (< 0.3 μm; mean, 136 μg/m3)
Trial: 23149871
Drug: Empagliflozin 100
RxNorm normalized name: Empagliflozin
DrugBank: Empagliflozin (DB09038)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Empagliflozin 100 mg
Trial: 23356556
Drug: Empagliflozin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin (all doses combined)
Trial: 21221770
Drug: Goserelin 10.8
RxNorm normalized name: goserelin 10.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 10.8 mg every 3 months
Trial: 3907989
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg twice daily)
Trial: 7923204
Drug: Prednisolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (10 mg twice daily)
Trial: 3289523
Drug: Diazepam (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (mean dose, 40.4 mg/d)
Trial: 31595600
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg galcanezumab
Trial: 31425468
Drug: Low-dose ketamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ketamine (LDK) at 2 μg·kg·min
Trial: 25527447
Drug: FAST (rapid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FAST (rapid identification and antibiotic susceptibility testing using PCR)
Trial: 21137035
Drug: High-flux hemodialysis
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flux hemodialysis treatment
Trial: 21137035
Drug: High-flux and
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flux and low-flux hemodialysis treatments
Trial: 10824629
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of rTFPI (0.2 mg/kg/h) with intravenous sorbitol (50 mg/min) for 4 hours in supine position
Trial: 8641622
Drug: ip mitoxantrone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ip mitoxantrone 10 mg/m2 every 2 weeks X 9
Trial: 8641622
Drug: ip floxuridine
RxNorm normalized name: Floxuridine
DrugBank: Floxuridine (DB00322)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ip floxuridine (FUDR) 3 g (total dose)/ day X 3 days every 3 weeks X 6 cycles
Trial: 1735812
Drug: Conventional diphtheria-tetanus-pertussis
RxNorm normalized name: DIPHTHERIA/TETANUS/PERTUSSIS VACCINE INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional diphtheria-tetanus-pertussis vaccine
Trial: 29453383
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBOT) + steroids
Trial: 29453383
Drug: Sham hyperbaric
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham hyperbaric air + steroids
Trial: 20509987
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Treatment (CBT) for anxiety disorders
Trial: 16052246
Drug: Lamotrigine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (200 mg daily) plus oxcarbazepine (600 mg twice daily)
Trial: 16052246
Drug: Lamotrigine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (200 mg daily) plus placebo
Trial: 16052246
Drug: Oxcarbazepine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (600 mg twice daily) plus placebo
Trial: 9688105
Drug: Dexfenfluramine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexfenfluramine (15 mg twice daily)
Trial: 7002181
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (10 mg three times daily)
Trial: 29712500
Drug: Fentanyl (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (continuous infusion of fentanyl)
Trial: 29712500
Drug: Control (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (continuous infusion of glucose)
Trial: 23895258
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment for alcohol and social phobia (9 sessions)
Trial: 23895258
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for alcohol use problems alone (9 sessions)
Trial: 21823550
Drug: Remoxy (extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxy (extended-release oxycodone) 5 mg bid to 20 mg bid, titrated during weeks 1-4 (10-80 mg/d) and fixed thereafter for 12 weeks
Trial: 17066515
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTA) + alpha-adrenergic antagonist
Trial: 29218448
Drug: Spa treatment
RxNorm normalized name: Salicylic Acid 5 mg in 1 mL TOPICAL LOTION [ageLOC LumiSpa Treatment Cleanser Acne]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa treatment including thermal water baths, physical therapy modalities, and exercises
Trial: 30065943
Drug: Spa treatment
RxNorm normalized name: Salicylic Acid 5 mg in 1 mL TOPICAL LOTION [ageLOC LumiSpa Treatment Cleanser Acne]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa treatment
Trial: 24782426
Drug: Flutamide (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (a selective non-steroidal AR antagonist)
Trial: 17689737
Drug: Direct coronary
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct coronary artery stenting with drug eluting stents
Trial: 16840657
Drug: rhIL-6 infusion
RxNorm normalized name: rhIL-15
DrugBank: Interleukin-15, human recombinant (DB17467)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-6 infusion (5 microg/h for 3 h)
Trial: 15383370
Drug: rhIL-6 infusion
RxNorm normalized name: rhIL-15
DrugBank: Interleukin-15, human recombinant (DB17467)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-6 infusion
Trial: 9270508
Drug: Tretinoin emollient
RxNorm normalized name: Tretinoin Emollient Topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin emollient cream 0.05% applied three times weekly
Trial: 9270508
Drug: Tretinoin emollient
RxNorm normalized name: Tretinoin Emollient Topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin emollient cream 0.05% applied once weekly
Trial: 18831420
Drug: Sham gel
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham gel
Trial: 28845523
Drug: Dupilumab 300
RxNorm normalized name: dupilumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dupilumab 300 mg weekly subcutaneous for 12 weeks
Trial: 18327364
Drug: Dorzolamide 2%
RxNorm normalized name: Brimonidine Tartrate 0.1%, Dorzolamide 2% Ophthalmic drops, solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide 2% 3 times daily and Timolol 0.5% twice daily
Trial: 15771757
Drug: Ursofalk suspension
RxNorm normalized name: ursodiol Oral Capsule [Ursofalk]
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursofalk suspension
Trial: 15771757
Drug: Ursofalk suspension
RxNorm normalized name: ursodiol Oral Capsule [Ursofalk]
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursofalk suspension and capsules
Trial: 1658138
Drug: UK 79300
RxNorm normalized name: UK-390957
DrugBank: UK-390957 (DB11719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK 79300 25 mg every 12 h (group 1)
Trial: 6302937
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of Human-fibroblast-derived (Beta) interferon (Hu1FN-B) at a dosage of 2-5 x 10(5) reference units daily for one week.
Trial: 20406224
Drug: Rupatadine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rupatadine 10 mg
Trial: 12867226
Drug: Hydroxyzine 50
RxNorm normalized name: hydroxyzine hydrochloride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine 50 mg
Trial: 15204391
Drug: Desmopressin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin (0.4 mg)
Trial: 15204391
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (after 4 weeks of monotherapy)
Trial: 12362011
Drug: Remaining subjects
RxNorm normalized name: Remain Gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remaining subjects in treatment group (after factoring out counseling)
Trial: 12362011
Drug: Those who
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Those who made at least one attempt to quit in treatment group
Trial: 9220235
Drug: 3% acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% acyclovir ointment
Trial: 20499046
Drug: rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone 4 mg twice daily for 16 weeks
Trial: 18340440
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic administered to the vocal folds
Trial: 12152675
Drug: Atorvastatin, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, 20 mg/day
Trial: 27578305
Drug: Ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingenol mebutate gel (IMB) for 3 days
Trial: 27578305
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy with methyl aminolevulinate (MAL-PDT) for a single session
Trial: 15949921
Drug: Deramciclane 30
RxNorm normalized name: Deramciclane
DrugBank: Deramciclane (DB06512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deramciclane 30 mg/day
Trial: 10396388
Drug: Pre-operative assessment
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative assessment by a trained ophthalmic nurse at the peripheral clinic
Trial: 7552478
Drug: CD4‐IgG 30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CD4‐IgG 30, 100, or 300 micrograms/kg weekly; 1,000 micrograms/kg once, twice, or three times per week; or 3,000 micrograms/kg twice weekly
Trial: 27552000
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment based on TNF alpha inhibitors and low‐carbohydrates calorie‐restricted diet
Trial: 27552000
Drug: TNF‐alpha inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF‐alpha inhibitors
Trial: 26686262
Drug: Text message
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text message reminders (daily tailored messages for 4 days)
Trial: 21982723
Drug: Sublingual testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual testosterone 0.25 mg
Trial: 21982723
Drug: Sublingual testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual testosterone (all doses)
Trial: 11113749
Drug: Neoadjuvant luteinizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant luteinizing hormone-releasing hormone-analogue treatment
Trial: 1354948
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (0.15 mg/kg x 2)
Trial: 1354948
Drug: Aminophylline (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (3 mg/kg) infusion
Trial: 3073045
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone (Rocephin), administered once daily for a mean duration of 9.9 days.